Healthledger Diagnostics: Financial Breakdown
Decoding financial health metrics of Healthledger Diagnostics
Total Revenue₹50.3 Lakh429%Prev. FY
Total Expenses₹50.2 Lakh371%Prev. FY
Profit After Tax₹13.3K111%Prev. FY
Total Assets₹7.8 Cr9%Prev. FY
Net Profit Margin0.3%102%Prev. FY
FAQs on Financials of Healthledger Diagnostics
Yes. In FY25, Healthledger Diagnostics reported a profit after tax of ₹1.6 Cr, making it profitable.
Healthledger Diagnostics's revenue grew 84.5% year-on-year, from ₹25.6 Cr in FY24 to ₹47.3 Cr in FY25.
Healthledger Diagnostics's estimated EBITDA for FY25 was ₹2.5 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Healthledger Diagnostics posted revenue of ₹47.3 Cr (up 84.5% YoY) and a profit after tax of ₹1.6 Cr. Explore the full financials of Healthledger Diagnostics here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links